BE901436A - Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant - Google Patents

Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant

Info

Publication number
BE901436A
BE901436A BE0/214284A BE214284A BE901436A BE 901436 A BE901436 A BE 901436A BE 0/214284 A BE0/214284 A BE 0/214284A BE 214284 A BE214284 A BE 214284A BE 901436 A BE901436 A BE 901436A
Authority
BE
Belgium
Prior art keywords
preparation
intermediates
compositions containing
therapeutic compositions
type antibiotics
Prior art date
Application number
BE0/214284A
Other languages
English (en)
Inventor
Gordon Gad Weingarten
Original Assignee
Glaxo Group Ltd Clarges House
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd Clarges House filed Critical Glaxo Group Ltd Clarges House
Publication of BE901436A publication Critical patent/BE901436A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Des composés de formule (I) dans laquelle R, R1 et R2, peuvent etre identiques ou différents, représentent chacun un atome d'hydrogène ou un groupe alkyle en C1-4, et R3 représente un groupe alkyle en C1-4, à condition que lorsque R1 et R2 représentent tous les deux des atomes d'hydrogène, R3 représente autre chose qu'un groupe méthyle. Ces esters de céfuroxime constituent des formes pour administration par voie orale de la céfuroxime antibiotique.
BE0/214284A 1984-01-03 1985-01-03 Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant BE901436A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400024A GB8400024D0 (en) 1984-01-03 1984-01-03 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
BE901436A true BE901436A (fr) 1985-07-03

Family

ID=10554497

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214284A BE901436A (fr) 1984-01-03 1985-01-03 Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant

Country Status (28)

Country Link
US (1) US4602012A (fr)
JP (1) JPH0791305B2 (fr)
KR (1) KR920001770B1 (fr)
AT (1) AT392279B (fr)
AU (1) AU578441B2 (fr)
BE (1) BE901436A (fr)
CA (1) CA1265512A (fr)
CH (1) CH666274A5 (fr)
DE (1) DE3500090A1 (fr)
DK (1) DK1585A (fr)
ES (2) ES8703884A1 (fr)
FI (1) FI83082C (fr)
FR (1) FR2557571B1 (fr)
GB (2) GB8400024D0 (fr)
GR (1) GR850007B (fr)
HK (1) HK105890A (fr)
HU (1) HU193076B (fr)
IL (1) IL73989A (fr)
IT (1) IT1178349B (fr)
LU (1) LU85719A1 (fr)
NL (1) NL8403974A (fr)
NO (1) NO165400C (fr)
NZ (1) NZ210725A (fr)
PH (1) PH22630A (fr)
PT (1) PT79787B (fr)
SE (2) SE466451B (fr)
SG (1) SG81390G (fr)
ZA (1) ZA8545B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8810392D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810395D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810396D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
DE59200935D1 (de) * 1991-03-11 1995-01-26 Schweizerhall Saeurefab Verfahren zur Herstellung von halogenierten Carbonsäureestern.
DE59200877D1 (de) * 1991-03-11 1995-01-19 Schweizerhall Saeurefab Verfahren zur Herstellung von chlorierten Carbonsäureestern.
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
DE60221787T2 (de) * 2002-03-04 2008-06-05 Orbus Pharma Inc. Zusammensetzungen mit schneller Freisetzung enthaltend Cefuroxime Axetil
WO2008155615A2 (fr) * 2007-06-18 2008-12-24 Orchid Chemicals & Pharmaceuticals Limited Procédé perfectionné pour la préparation d'un antibiotique de la famille des céphalosporines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1572993A (en) * 1976-02-16 1980-08-13 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1093549A (fr) * 1976-02-16 1981-01-13 Michael Gregson Traduction non-disponible
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (fr) * 1976-02-16 1981-01-27 Michael Gregson Traduction non-disponible
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
IT1210868B (it) * 1982-04-01 1989-09-29 Opos Biochimica Srl Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process

Also Published As

Publication number Publication date
PT79787A (en) 1985-02-01
DE3500090A1 (de) 1985-07-11
NO165400B (no) 1990-10-29
ES8705891A1 (es) 1987-05-16
GB2152504A (en) 1985-08-07
IL73989A0 (en) 1985-04-30
FI850012L (fi) 1985-07-04
AU3704684A (en) 1985-07-11
GB8400024D0 (en) 1984-02-08
CA1265512A (fr) 1990-02-06
HUT37800A (en) 1986-02-28
DK1585D0 (da) 1985-01-02
IT1178349B (it) 1987-09-09
SG81390G (en) 1990-11-23
FI83082C (fi) 1991-05-27
CH666274A5 (de) 1988-07-15
IL73989A (en) 1988-10-31
LU85719A1 (fr) 1985-10-22
ATA1285A (de) 1990-08-15
FR2557571A1 (fr) 1985-07-05
NO850010L (no) 1985-07-04
SE466451B (sv) 1992-02-17
DE3500090C2 (fr) 1993-09-23
HK105890A (en) 1990-12-21
IT8449383A1 (it) 1986-07-01
KR850005446A (ko) 1985-08-26
SE8500011L (sv) 1985-07-04
JPS60172989A (ja) 1985-09-06
NO165400C (no) 1991-02-06
JPH0791305B2 (ja) 1995-10-04
AT392279B (de) 1991-02-25
ES8703884A1 (es) 1987-03-01
PH22630A (en) 1988-10-28
GB2152504B (en) 1987-10-07
NL8403974A (nl) 1985-08-01
FR2557571B1 (fr) 1987-04-17
FI83082B (fi) 1991-02-15
HU193076B (en) 1987-08-28
US4602012A (en) 1986-07-22
FI850012A0 (fi) 1985-01-02
DK1585A (da) 1985-07-04
GB8500091D0 (en) 1985-02-13
AU578441B2 (en) 1988-10-27
ES539311A0 (es) 1987-03-01
KR920001770B1 (ko) 1992-03-02
PT79787B (en) 1986-12-11
ZA8545B (en) 1986-09-24
IT8449383A0 (it) 1984-12-31
GR850007B (fr) 1985-05-03
NZ210725A (en) 1988-02-12
SE8500011D0 (sv) 1985-01-02
ES552577A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
BE901436A (fr) Antibiotiques du type cephalosporine, leur procede de preparation, intermediaires pour leur preparation et compositions therapeutiques les contenant
EP0648778A3 (fr) 4 Dérivés 11-benzaldoximes de estradiene, un procédé pour leur préparation et les compositions pharmaceutiques les contenant.
BE901576A (fr) Composes heterocycliques.
AU3091084A (en) 1,8-naphthyridine derivatives
CA2102697A1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant
EP0648779A3 (fr) Nouveaux dérivés 11-benzaldoxime, 17-bêta-méthoxy, 17 alpha-méthoxy méthyle de estradiène, un procédé pour leur préparation et les compositions pharmaceutiques les contenant.
CA2078520A1 (fr) Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant
ATE15048T1 (de) 4''-epi erythromycin a und seine derivate brauchbar wie antibakterielle mittel.
CA2161297A1 (fr) Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2637286A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP0262053A3 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
CA2066304A1 (fr) Composition pharmaceutique pour le traitement de maladies autoimmunes
OA08972A (fr) Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leursprocédés de préparation et les compositions pharmaceutiques qui les contiennent
FR2391191A1 (fr) Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
AU579665B2 (en) 2-pyridine-thiol derivatives
BE1003229A3 (fr) Compositions pharmaceutiques antimicrobiennes, a base d'une combinaison synergique, pour l'application topique et leur procede de preparation.
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.
BE900718A (fr) Nouveaux derives du carbapeneme, leur preparation et leur utilisation comme medicaments.
AU769882C (en) Medicament containing platinum complex compounds and the use thereof
DE3468875D1 (en) Substituted isoquinoline derivatives, method for their preparation, and pharmaceutical compositions containing these compounds
BE902911A (fr) Derives n-imidazolyliques et leur preparation
BE1003280A3 (fr) Derives oxo-isoindoliniques optiquement actifs.
BE902381A (fr) Antibiotiques de cephalosporine, leur preparation et compositions pharmaceutiques les contenant.
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD CLARGES HOUSE

Effective date: 19950131